期刊
PHARMACEUTICALS
卷 12, 期 2, 页码 -出版社
MDPI
DOI: 10.3390/ph12020052
关键词
dotatate; drugs; inotersen; Lutathera; oligonucleotides; Onpattro; patisiran; peptides; pharmaceutical market; Tegsedi
资金
- University of KwaZulu-Natal (South Africa)
- Spanish Ministry of Economy, Industry and Competitiveness (MINECO) [CTQ2015-67870-P]
- Generalitat de Catalunya (Spain) [2017 SGR 1439]
- National Research Foundation (NRF) (CSUR) [105892]
- National Research Foundation (NRF) (Blue Sky's Research Programme) [110960]
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
